Immunohistochemical detection of prothymosin alpha in pituitary adenomas--a new marker of tumor recurrence?

Folia Histochem Cytobiol. 2009;47(4):559-62. doi: 10.2478/v10042-009-0096-2.

Abstract

Forty pituitary adenomas were immunostained with an antibody raised against the C-terminal fragment (101-109) of human prothymosin alpha (PT alpha). The strong positive immunostaining was found in the subpopulation of cell nuclei and intratumoral vessel walls, while the cytoplasm of adenoma cells was slightly immunopositive. The significantly higher percentage of PT alpha-positive cell nuclei was found in recurrent pituitary adenomas as compared with primary tumors. However, there was no correlation between the percentage of PT alpha-positive cell nuclei and Ki-67 indices. Gonadotropinomas were characterized by higher nuclear PT alpha expression in comparison to other pituitary adenomas, which is probably linked with the high recurrence rate of these tumors. It is suggested that PT alpha immunostaining may be helpful in predicting the pituitary tumor recurrence. However, this conclusion needs to be confirmed in further prospective studies. Moreover, PT alpha may be also useful as an immunohistochemical marker of the intratumoral microvasculature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma* / metabolism
  • Adenoma* / pathology
  • Biomarkers, Tumor / metabolism*
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / metabolism
  • Pituitary Neoplasms* / metabolism
  • Pituitary Neoplasms* / pathology
  • Protein Precursors / metabolism*
  • Recurrence
  • Thymosin / analogs & derivatives*
  • Thymosin / metabolism

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Protein Precursors
  • prothymosin alpha
  • Thymosin